THE EFFECTS OF SPEECH AND LANGUAGE THERAPY FOR A CASE OF DYSARTHRIA ASSOCIATED WITH PARKINSONS-DISEASE

被引:0
|
作者
LEDORZE, G [1 ]
DIONNE, L [1 ]
RYALLS, J [1 ]
JULIEN, M [1 ]
OUELLET, L [1 ]
机构
[1] HOP JACQUES VIGER,MONTREAL,PQ,CANADA
来源
EUROPEAN JOURNAL OF DISORDERS OF COMMUNICATION | 1992年 / 27卷 / 04期
关键词
THERAPY; DYSARTHRIA; PROSODY; PARKINSONS DISEASE;
D O I
暂无
中图分类号
G2 [信息与知识传播];
学科分类号
05 ; 0503 ;
摘要
We report the results of a single-subject multiple baseline across behaviours experiment of a 74-year-old woman presenting with Parkinson's disease. Her speech was typical of a hypokinetic dysarthria. The main features of her dysarthric speech were: a restriction in the modulation of fundamental frequency, an inappropriate pitch level and a rate disturbance. Three measures of prosody were operationally defined as follows: (1) linguistic modulation of fundamental frequency, (2) mean fundamental frequency and (3) rate. Treatment focused on ameliorating these aspects employing a multiple baseline design. Measures during and post-therapy documented improvement for each of these three aspects of prosody. Independent judges were also more capable of understanding her speech and her speech prosody after therapy. Upon follow-up measures 10 weeks later, most of the improvement was maintained.
引用
收藏
页码:313 / 324
页数:12
相关论文
共 50 条
  • [21] A CLINICAL AND PHARMACOKINETIC CASE-STUDY OF AN INTERACTION OF LEVODOPA AND ANTITUBERCULOUS THERAPY IN PARKINSONS-DISEASE
    WENNING, GK
    OCONNELL, MT
    PATSALOS, PN
    QUINN, NP
    MOVEMENT DISORDERS, 1995, 10 (05) : 664 - 667
  • [22] HYPOKINESIA OF ASSOCIATED MOVEMENT IN PARKINSONS-DISEASE - A SYMPTOM IN EARLY STAGES OF THE DISEASE
    HOSHIYAMA, M
    KANEOKE, Y
    KOIKE, Y
    TAKAHASHI, A
    WATANABE, S
    JOURNAL OF NEUROLOGY, 1994, 241 (09) : 517 - 521
  • [23] IMPAIRED LEVODOPA RESPONSE IN PARKINSONS-DISEASE DURING MELANOMA THERAPY
    MERELLO, M
    ESTEGUY, M
    PERAZZO, F
    LEIGUARDA, R
    CLINICAL NEUROPHARMACOLOGY, 1992, 15 (01) : 69 - 74
  • [24] EFFECTS OF SELEGILINE (DEPRENYL) ON COGNITION IN EARLY PARKINSONS-DISEASE
    DALRYMPLEALFORD, JC
    JAMIESON, CF
    DONALDSON, IM
    CLINICAL NEUROPHARMACOLOGY, 1995, 18 (04) : 348 - 359
  • [25] PROBLEMS WITH LONG-TERM LEVODOPA THERAPY FOR PARKINSONS-DISEASE
    MARSDEN, CD
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 : S32 - S44
  • [26] CLOZAPINE THERAPY FOR PARKINSONS-DISEASE AND OTHER MOVEMENT-DISORDERS
    PFEIFFER, C
    WAGNER, ML
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (24): : 3047 - 3053
  • [27] PARKINSONS-DISEASE - EPIDEMIOLOGY, (DIFFERENTIAL) DIAGNOSIS, THERAPY, RELATION TO DEMENTIA
    OERTEL, WH
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (3A): : 386 - 389
  • [28] TOLERABILITY OF LONG-TERM SELEGILINE THERAPY IN PARKINSONS-DISEASE
    VERMERSCH, P
    PETIT, H
    THERAPIE, 1992, 47 (01): : 75 - 78
  • [29] HALLUCINATIONS IN PARKINSONS-DISEASE - CHARACTERISTICS AND ASSOCIATED CLINICAL-FEATURES
    HAESKEDEWICK, HC
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1995, 10 (06) : 487 - 495
  • [30] ACOUSTIC ANALYSIS OF SPEECH PROSODY IN HUNTINGTONS AND PARKINSONS-DISEASE - A PRELIMINARY-REPORT
    HERTRICH, I
    ACKERMANN, H
    CLINICAL LINGUISTICS & PHONETICS, 1993, 7 (04) : 285 - 297